Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer
British journal of surgery2005Vol. 92(1), pp. 5–13
Citations Over TimeTop 10% of 2005 papers
Abstract
Evidence for D2 dissection is inconclusive. No overall survival advantage has emerged, but some patients with intermediate stage disease may benefit. Excess operative mortality appears to be associated with pancreatico-splenectomy, low case volume and lack of specialist training.
Related Papers
- → Disadvantages of Complete No. 10 Lymph Node Dissection in Gastric Cancer and the Possibility of Spleen-Preserving Dissection: Review(2020)13 cited
- Results of curative gastrectomy for carcinoma.(1994)
- → Do patients with pN0 gastric cancer benefit from prophylactic extended lymphadenectomy?(2011)3 cited
- → Clinical studies on the correlation between immunologic status and total gastrectomy combined with splenectomy(1980)6 cited
- → [Brief discussion on prevention of the secondary damage in the procedures of D2 lymphadenectomy for gastric cancer].(2019)